In this process, nucleotide bases in donor cells are edited so that the gene for CD7 (a genetic marker in blood cancers) is changed from cytosine to thymine, thus producing a ‘stop codon’ that terminates the production of CD7. The gene discussed is CD7; the disease is hematopoietic and lymphoid system neoplasm.